Crestline Management, L.P. reported 2 holdings worth US$29.3M as of Sep 30, 2026 (Form 13F)
As of Sep 30, 2026 · Filed Nov 16, 2026
Crestline Management, L.P. reported 2 holdings worth US$29.3M as of Sep 30, 2026. Largest: Denali Therapeutics Inc., Sana Biotechnology, Inc. and 8x8 Inc. Filed Nov 16, 2026 (Form 13F).
- Holdings
- 2
- Value as reported
- US$29.3M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|---|---|---|
| Denali Therapeutics Inc. | 1.31M | US$27.1M | 92.5% |
| Sana Biotechnology, Inc. | 756K | US$2.2M | 7.5% |
| 8x8 Inc | 0 | US$0 | 0.00% |
Source
Download original · View original at SEC